The experimental myocarditis of mice immunized with group A streptococcal cytoplasmic membrane fraction extracted from L-forms.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H Sakamoto.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The general pharmacological properties of guanabenz (Wy-8678), a new centrally acting antihypertensive agent, on the central nervous system were studied in mice, rats and rabbits, and they were compared with those of clonidine. In mice, guanabenz (1-30 mg/kg, i.p.) showed overt sedation dose-dependently, like clonidine (0.3 or 1 mg/kg, i.p.). At doses (2.5-20 mg/kg, p.o.) not causing muscle relaxant action, guanabenz impaired rotarod performance, inhibited conditioned avoidance responses and maximum electroshock seizure, prolonged thiopental sleeping time, and lowered body temperature in rats. These central depressant effects were observed following oral administration of clonidine at much lower dose levels. In rabbits, neither guanabenz (5-20 mg/kg, p.o.) nor clonidine (0.5 or 1 mg/kg, p.o.) affected body temperature. These findings suggest that the central depressant activities of guanabenz, qualitatively very similar to clonidine, are much less potent than those of clonidine.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Circular dichroic spectra of NADPH-adrenodoxin reductase, adrenodoxin and the complex between oxidized adrenodoxin reductase and oxidized adrenodoxin were studied. A 1 : 1 complex formation between adrenodoxin reductase and adrenodoxin resulted in the appearance of a distinct difference CD spectrum, which was obtained by subtraction of the sum of their CD spectra from the CD spectrum of the mixture of the two proteins. The difference CD spectrum showed a broad trough between 500 and 600 nm and CD extrema at 452, 383, and 350 nm. This spectrum may reflect a change in the environment of either or both of the protein chromophores. By applying the curve-fitting method to analyze the ellipticity change at 452 nm of the difference CD spectrum obtained on titration of a fixed amount of adrenodoxin reductase with various amounts of adrenodoxin, we directly obtained a value of 4.56 x 10(-7) M (S.D. 9.58 x 10(-8) M) as the dissociation constant of the oxidized complex. We also studied the change of the difference ellipticity induced by the addition of salt and obtained dissociation constants for the oxidized complex at various concentrations of NaCl. These values were larger than those obtained previously by kinetic methods, measurements of NADPH-cytochrome c reductase and NADPH-DCIP reductase activities. Further, we examined the relationship between the change of these activities on the addition of salt and the complex concentration calculated using the dissociation constant obtained in this study and found that the change of these activities could not be attributed simply to dissociation of the oxidized complex.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This study was designed to investigate the oxytocin (OT) specific binding receptors in 20,000 x g pellets of nonpregnant, first trimester and term human myometria. The receptor analysis was done using the lower uterine segment at term and the lower portion of the anterior uterine body in nonpregnant and first trimester subjects, and no difference was found in the myometrial receptor concentrations in the various uteri. The mean +/- S.D. values of the receptor dissociation constants were 3.33 +/- 0.50, 2.71 +/- 1.03 and 1.87 +/- 0.30 nM and the number of binding sites was 0.30 +/- 0.10, 0.50 +/- 0.10 and 1.50 +/- 0.50 pmol/mg protein at each stage studied, indicating that the gestational increase of uterine sensitivity to OT is due to the increase in myometrial OT binding sites as well as its binding affinity. Further, myometrial OT binding before and after the onset of labor was studied and a marked decrease in total myometrial OT binding was noticed; 35.6 +/- 13.0% before and 20.2 +/- 5.0% after. This decrease was thought to be due to the decrease in the number of binding sites from 1.50 +/- 0.50 to 0.74 +/- 0.21 pmol/mg protein after the onset of labor (p less than 0.01). No changes were found in the dissociation constants. Thus it seems that OT and its receptor coupling triggers labor or is involved in the early steps of labor.
This study was designed to investigate the oxytocin (OT) receptor activities in the human myometrial specimen throughout the course of pregnancy and in labor. The 3H-labeled OT with adequate specific activity (24 Ci/mM) and biologic activity (350 IU/mg) was employed for the OT radioreceptor assay and the apparent dissociation constant (Kds) and the number of binding sites (NBS) were analyzed by Scatchard plot. These activities were predominantly found in 20,000 xg pellets of the myometrial specimens and its binding activities were 2.2 +/- 0.1 nmol/mg protein that were assessed to be composed of two binding fractions: High-affinity--low capacity receptor fraction and low affinity--high capacity fraction. The gestational increase of the binding affinity was significant and so was the increase of the capacity, and the Kd was 1.87 +/- 0.30 nM and the NBS was 1.50 +/- 0.50 pmol/mg protein in the full term specimens and both were significantly higher than those of the nonpregnant specimens (p less than 0.01). When active labor was initiated, a significant decrease of the binding capacity (0.74 +/- 0.21 pmol/mg protein) was found, regardless of the mode of onset of labor; i.e. spontaneous or induced labor, while the binding affinity remained unchanged. These findings suggest that the gestational increase of the uterine sensitivity to OT is due to the increase of both binding affinity and capacity of the OT receptors. And there are OT and OT receptor interaction actively involved during the active stage of labor and this interaction seems to be coupled with the contractile process but is apparently modified when active labor had been already initiated.
Explore the source record for details and available documents.